WHO should adjust its global strategy for cervical cancer prevention

被引：5

作者：

Suba, Eric J. ^{[1
,2
]}

Donnelly, Amber D. ^{[3
]}

Van Duong, Dang ^{[4
]}

Mena, Ludwing Erick Gonzalez ^{[5
]}

Neethling, Greta S. ^{[6
]}

Van Thai, Nguyen ^{[7
]}

机构：

[1] Global Cerv Canc Prevent Project, San Francisco, CA 94158 USA

[2] Tuskegee Univ, Natl Ctr Bioeth Res & Hlth Care, Tuskegee, AL 36088 USA

[3] Univ Nebraska Med Ctr, Omaha, NE USA

[4] Inst Canc Res Cooperat & Community Hlth Dev, Hue City, Vietnam

[5] Inst Epidemiol Diag & Reference, Ciudad De Mexico, Mexico

[6] Stellenbosch Univ, Fac Med & Hlth Sci, Cape Town, Western Cape, South Africa

[7] Ho Chi Minh City Oncol Hosp, Ho Chi Minh City, Vietnam

来源：

BMJ GLOBAL HEALTH | 2023年 / 8卷 / 06期

关键词：

Health policy; Public Health; Screening; Prevention strategies; Cancer; LOW-RESOURCE SETTINGS; VISUAL INSPECTION; SCREENING METHODS; HPV; CYTOLOGY; PROVINCE; TRIAL;

D O I：

10.1136/bmjgh-2023-012031

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页数：6

共 50 条

[31] WHO Programme on Cancer Control: developing a global strategy for cancer, a review
Oliver, G
[J]. EUROPEAN JOURNAL OF CANCER CARE, 1999, 8 (01) : 10 - 11
[32] (At Least) Once in Her Lifetime: Global Cervical Cancer Prevention
Castle, Philip E.
Pierz, Amanda
[J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2019, 46 (01) : 107 - +
[33] Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos, Joanne
Narod, Steven A.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (05) : 1245 - 1251
[34] Breast cancer prevention at last - But who should take tamoxifen or raloxifene?
White, K
[J]. JOURNAL OF WOMENS HEALTH, 1998, 7 (05): : 495 - 496
[35] ENVIRONMENTAL FACTORS IN CERVICAL CANCER - AN APPROACH TO ITS PREVENTION
WYNDER, EL
[J]. BRITISH MEDICAL JOURNAL, 1955, 1 (MAR26): : 743 - 747
[36] Cervical cancer: Advances in prevention and knowledge of its etiology
Bosch, FX
[J]. SALUD PUBLICA DE MEXICO, 2003, 45 : S297 - S298
[37] WHO global strategy for the prevention and control of sexually transmitted infections: time for action
Lewis, D. A.
Latif, A. S.
Ndowa, F.
[J]. SEXUALLY TRANSMITTED INFECTIONS, 2007, 83 (07) : 508 - 509
[38] Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?
Seda Kahraman
Ulviye Esra Erbas
Bulent Yalcin
[J]. Medical Oncology, 2022, 39
[39] Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?
Kahraman, Seda
Erbas, Ulviye Esra
Yalcin, Bulent
[J]. MEDICAL ONCOLOGY, 2022, 39 (03)
[40] Conservative surgery for early stage cervical cancer: Who should we offer it to?
Eiriksson, Lua
Covens, Allan
[J]. GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 173 - 174

← 1 2 3 4 5 →